↓ Skip to main content

Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive…

Overview of attention for article published in BMC Cancer, November 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
481 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Protocol for the “Chemobrain in Motion – study” (CIM – study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy
Published in
BMC Cancer, November 2018
DOI 10.1186/s12885-018-4992-3
Pubmed ID
Authors

Max Oberste, Nils Schaffrath, Katharina Schmidt, Wilhelm Bloch, Elke Jäger, Karen Steindorf, Philipp Hartig, Niklas Joisten, Philipp Zimmer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 481 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 481 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 62 13%
Student > Bachelor 56 12%
Student > Ph. D. Student 33 7%
Researcher 30 6%
Other 23 5%
Other 69 14%
Unknown 208 43%
Readers by discipline Count As %
Nursing and Health Professions 72 15%
Sports and Recreations 54 11%
Medicine and Dentistry 49 10%
Psychology 23 5%
Neuroscience 14 3%
Other 47 10%
Unknown 222 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2018.
All research outputs
#18,655,700
of 23,112,054 outputs
Outputs from BMC Cancer
#5,472
of 8,390 outputs
Outputs of similar age
#270,118
of 352,386 outputs
Outputs of similar age from BMC Cancer
#130
of 201 outputs
Altmetric has tracked 23,112,054 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,390 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,386 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.